Back to Screener

Healthcare

Lineage Cell Therapeutics, Inc.(LCTX)

Live Price

Offline

$1.22

-3.17% today

1Y Change

+31.25%

Window

Jun 26, 2025 โ†’ Jun 24, 2026

Market Cap
$380.00M
Revenue Growth
+53.2%
EPS Growth
-201.1%
Dividend Yield
0.0%

Coverage: 249 bars ยท Jun 26, 2025 โ†’ Jun 24, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Lineage Cell Therapeutics, Inc. (LCTX) is a Healthcare stock with a market cap of $380.00M and listed on AMEX. The stock last traded around $1.22 and up 31.3% across the available one-year price window (Jun 26, 2025 โ†’ Jun 24, 2026). Baseline metrics include revenue growth of +53.2%, EPS growth of -201.1%, a dividend yield of 0.0%. What stands out right now is revenue +53.2%, EPS -201.1%, free cash flow +17.8% with operating margin -251.6% and ROIC -33.1%. Valuation already assumes a fairly strong business story at price/sales 26.1. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines LCTX price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Benchmark Edge

LCTX vs SPY, QQQ, and Sector ETFs

Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.

Shared 1Y chart + MAX history table

LCTX

โ€”

Normalized return

SPY

--

S&P 500

Excess Return

--

Relative to SPY

LCTX Max Drawdown

-39.29%

Trailing 1Y

SPY Max Drawdown

โ€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for LCTX and SPY.

Calendar-year return history is still loading or unavailable.

Earnings Reports

๐Ÿ“… Last reportedMay 12, 2026
PeriodB/MEPSEPS ฮ”RevenueRev ฮ”Report
โ€”
May 12, 26
โ€”
Est -0.02
โ€”
โ€”
Est 5033.8B
โ€”
May 12
โ€”
Mar 5, 26
โœ“
0.00
Est -0.04
+109.2%
6600.0B
Est 1959.6B
+236.8%
Mar 5
โ€”
Nov 6, 25
โœ—
-0.13
Est -0.02
-550.0%
3681.0B
Est 1959.6B
+87.8%
Nov 6
โ€”
Aug 12, 25
โœ“
-0.01
Est -0.02
+50.0%
2765.0B
Est 1888.9B
+46.4%
Aug 12
โ€”
May 13, 25
โ€”
-0.02
Est -0.02
0.0%
1502.0B
Est 1724.3B
-12.9%
May 13
โ€”
Mar 10, 25
โœ“
-0.01
Est -0.04
+75.0%
2868.0B
Est 1361.0B
+110.7%
Mar 10
โ€”
Nov 14, 24
โœ—
-0.02
Est -0.01
-53.5%
3779.0B
Est 1621.2B
+133.1%
Nov 14
โ€”
Aug 8, 24
โœ“
-0.03
Est -0.05
+40.0%
1408.0B
Est 970.0B
+45.1%
Aug 8
โ€”
May 9, 24
โœ—
-0.04
Est -0.04
-4.4%
1444.0B
Est 1360.0B
+6.2%
May 9
โ€”
Mar 7, 24
โœ—
-0.03
Est -0.02
-30.0%
2088.0B
Est 1310.0B
+59.4%
Mar 7
โ€”
Nov 9, 23
โœ—
-0.04
Est -0.04
-6.7%
1246.0B
Est 1130.0B
+10.3%
Nov 9
โ€”
Aug 10, 23
โœ—
-0.03
Est -0.02
-32.3%
3225.0B
Est 2200.0B
+46.6%
Aug 10
โ€”
May 11, 23
โœ—
-0.03
Est -0.02
-21.8%
2386.0B
Est 2010.0B
+18.7%
May 11
โ€”
Mar 9, 23
โœ—
-0.03
Est -0.03
-19.2%
1915.0B
Est 2570.0B
-25.5%
Mar 9
โ€”
Nov 10, 22
โœ—
-0.04
Est -0.04
-14.3%
2998.0B
Est 3896.9B
-23.1%
Nov 10
โ€”
Aug 11, 22
โœ—
-0.04
Est -0.04
-6.7%
4553.0B
Est 3683.9B
+23.6%
Aug 11
โ€”
May 12, 22
โœ—
-0.04
Est -0.03
-17.6%
5237.0B
Est 7323.6B
-28.5%
May 12
โ€”
Mar 10, 22
โœ—
-0.05
Est -0.01
-264.2%
960.0B
Est 840.0B
+14.3%
Mar 10
โ€”
Nov 10, 21
โ€”
-0.05
Est -0.05
0.0%
2202.0B
Est 2202.0B
0.0%
Nov 10
โ€”
Aug 12, 21
โœ—
-0.03
Est -0.03
-18.2%
441.0B
Est 410.0B
+7.6%
Aug 12
No upcoming earnings in the next 90 days

Next Step

Connect reports to catalysts

Earnings pages get much more useful when they are tied back to upcoming dates, expectations, and peer setups.

Read the earnings calendar guideOpen the calendar screener